Stem Cell Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Stem Cell Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Stem Cell Transplantation
High-dose chemotherapy and stem cell transplant eradicates relapsed primary effusion lymphoma
August 14th, 2006
High-dose chemotherapy and stem cell transplantation successfully eradicates relapsed primary effusion lymphoma. "Primary effusion lymphoma (PEL) is a recently recognized disease that occurs most often in immunosuppressed patients, either with human immunodeficiency virus (HIV) or in the post-transplantation setting, and it occasionally occurs in nonimmunosuppressed patients. "Patients present with lymphomatous effusions in serous cavities-pleura, pericardium, or peritoneum-without any identifiable tumor mass," wrote investigators in South Korea. According to the authors, "PEL rarely responds to systemic chemotherapy, and the...
Source: Stem Cell Week (2006-08-14)
|
